by Clinical Neuropsychologist | Wednesday, September 11, 2024 | Dementia
Abstract INTRODUCTION We examined the relations of misfolded alpha synuclein (α-synuclein) with Alzheimer’s disease (AD) biomarkers in two large independent cohorts. METHODS We included Biomarkers for Identifying Neurodegenerative Disorders Early and Reliably...
by Clinical Neuropsychologist | Wednesday, September 11, 2024 | Dementia
Abstract INTRODUCTION Word-list recall tests are routinely used for cognitive assessment, and process scoring may improve their accuracy. We examined whether Alzheimer’s Disease Assessment Scale–Cognitive subscale (ADAS-Cog) derived, process-based digital...
by Clinical Neuropsychologist | Wednesday, September 11, 2024 | Dementia
Abstract The magnetic resonance imaging (MRI) Core has been operating since Alzheimer’s Disease Neuroimaging Initiative’s (ADNI) inception, providing 20 years of data including reliable, multi-platform standardized protocols, carefully curated image data,...
by Clinical Neuropsychologist | Tuesday, September 10, 2024 | Dementia
Abstract INTRODUCTION Frontotemporal dementia (FTD) is characterized by phenotypic and genetic heterogeneities. However, reports on the large Chinese FTD cohort are lacking. METHODS Two hundred forty-eight patients with FTD were enrolled. All patients and 2010 healthy...
by Clinical Neuropsychologist | Tuesday, September 10, 2024 | Dementia
Abstract INTRODUCTION Few studies have examined the relationship between education and cognition among the oldest–old. METHODS Cognitive assessments were conducted biannually for 803 participants (62.6% women) of LifeAfter90, a longitudinal study of individuals ≥ 90...
